Technology | May 21, 2014

FDA Clears Siemens Somatom Force CT System

Freezes motion with free-breathing CT, advances preventive care initiatives with low-dose lung/colon imaging

Force, CT, Siemens, dual energy CT

May 21, 2014 — The U.S. Food and Drug Administration (FDA) cleared Siemens Healthcare's Somatom Force computed tomography (CT) system, its next generation in dual-source CT. With two sets of Siemens’ X-ray tubes and detectors, the Somatom Force extends advanced imaging to all patients, including some of the most challenging: young children, patients with renal insufficiency and patients who are unable to hold their breath. The Somatom Force overcomes imaging limitations, making low-dose CT available for an even broader array of patients. With the power reserves of its Vectron tube, the Somatom Force delivers routine adult imaging with fast, low-dose protocols.

Kidney-friendly Scanning

For years, CT imagers have been investigating the usage of different energy levels (kilovoltage or “kV”) to elicit an enhanced contrast-to-noise ratio and lower patient radiation dose. Lowering kV levels also can potentially increase enhancement of contrast medium, so less contrast may be necessary. This practice had limitations because earlier generations of CT scanners could not sufficiently power imaging at very low kV levels except when imaging children or very small adults. In early investigational research with the Somatom Force, radiologists have observed low, previously unachievable kV imaging results that are enabled by the Force’s power reserves.¹

“The massively enhanced tube power of the Somatom  Force enables imaging that can be acquired at very low kV settings — and thus at a lower level of radiation dose — routinely in adult patients and even those of a larger body type. In the past, these low kV settings would have resulted in noisy, nondiagnostic studies,” said Joseph Schoepf, M.D., director of CT research and development and professor of radiology and cardiology at Medical University of South Carolina.

Due to its low kV imaging, the Somatom Force broadens CT’s application for patients with renal insufficiency. While necessary for conventional CT imaging, iodine contrast medium can place a burden on the kidneys, especially for older patients or those with chronic kidney disease. Previously, clinicians had two options: scan without contrast or avoid scanning entirely. The Somatom Force extends CT’s use for these patients, especially in urgent situations when they can most benefit.

An author of numerous published studies on the benefits of low kV imaging and an internationally recognized expert in neuroradiology, Lawrence Tanenbaum, M.D., FACR, noted, "The Somatom Force enables routine 70 kV imaging — a technique poised to make a tremendous impact in day-to-day scanning of adult and pediatric patients, with benefits such as decreased radiation dose and impressive time-resolved imaging."

Freezing Motion

With the industry’s fastest, most versatile scanning mode, the Somatom Force enables the user to perform an entire adult chest, abdomen and pelvis study in only one second, so patients need not hold their breath. For example, patients who present with shortness of breath and are evaluated for pulmonary embolism can now be imaged with no breath hold, thanks to the Somatom Force’s Turbo Flash Mode. With no need for a patient breath hold, the healthcare organization can make faster, more confident decisions and can better deliver timely intervention. In cardiac imaging, the Somatom Force can obtain an entire study within a quarter of a heartbeat at a native temporal resolution of 66 ms — the speed required to freeze even the fastest-moving anatomy such as the right coronary artery.

Preventative Care

The Somatom Force also may enable low-dose imaging in lung and colon exams.² Low-dose imaging is attributable to two spectral filters known as Selective Photon Shields that optimize the X-ray spectrum to significantly improve air/soft-tissue contrast. Patients who are diagnosed with lung or colon cancer are likely to undergo additional follow-up imaging studies that can now be delivered at a continually low dose to enable more decisive treatment and post-therapy evaluations.

References:

1. With the low kV/high mA capabilities of the VECTRON tube, SOMATOM Force allows scanning with a very high tube current of up to 1300 mA at 70, 80 and 90 kV, such that a high tube output even for these low kV settings can be achieved. Along with SOMATOM Force’s unique Turbo Flash Mode, this scan configuration is also available for conventional spiral or sequential scanning.

2. The SOMATOM Force may achieve the same contrast-to-noise level (in terms of image pixel noise) in the image in reduced dose.

For more information: www.siemens.com/healthcare

Related Content

iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Feature | Computed Tomography (CT) | July 03, 2018 | By Jeff Zagoudis
Stroke is the fifth leading cause of death in the United States, responsible for more than 140,000 deaths in some of
Neusoft Medical Systems USA Introducing NeuViz 16 Essence CT at AHRA 2018
Technology | Computed Tomography (CT) | June 27, 2018
At the 2018 Association for Medical Imaging Management (AHRA) Annual Meeting, July 22-25 in Orlando, Fla., Neusoft...
Smoking and Diabetes Linked to Brain Calcifications
News | Neuro Imaging | June 26, 2018
People who smoke or have diabetes may be at increased risk of calcifications in a region of the brain crucial to memory...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Overlay Init